The Table 1 summarizes the main alterations of the endocannabinoid receptors (CB1 and CB2), their endogenous ligands (AEA and 2-AG), and the enzymes responsible for their synthesis and degradation (NAPE-PLD, FAAH, MAGL) in pediatric inflammatory and immune diseases. This evidence concerns the gene CNR2 and immune system disorder.